Trouble reading this email? View it in your browser
European Federation of Pharmaceutical Industries and Associations EFPIA Newsletter 27 July 2023
      Exciting news! You can now apply to IHI calls 4 and 5!

“The topics in these calls show how IHI makes concrete contributions to key European policies. Our two topics on the environmental impacts of healthcare are in line with the goals of the European Green Deal. We have topics that advance the EU’s aim of replacing, reducing and refining the use of animals in research. We also have a topic that will help to boost the involvement of people from underserved patient populations in clinical trials.” said IHI’s interim Executive Director, Dr Hugh Laverty.

 

 
 
      News
 
  27 July 2023 EFPIA statement in response to the Commissions Communication on the European Citizen’s initiative...

EFPIA members are committed to the science-based phase-in of methods to replace the use of animals for scientific purposes...

Read more →
 
 
 
      Just published | White Paper on Climate Change

Today we publish a White Paper outlining how EFPIA member companies are actively engaged – on site and along the value chain – in groundbreaking and ambitious projects to rise to the challenges posed by climate change.

 

Beyond case studies, you will find the outcomes of an internal survey conducted in 2022 that highlights the pharmaceutical industry's commitments to making a positive impact on the lives of patients, while operating sustainably.

 

 

 

 

 

 

 

 

 

 

 
 
 
      Events
 
 
12 SEP 2023
  Unlocking the potential of new oncology treatments Virtual event

A cross-stakeholder discussion on improving the understanding, acceptance and use of oncology-relevant endpoints in...

Learn more →
 
 
 
26 SEP 2023
  Rethinking Alzheimer’s disease: Moving towards a new Alzheimer’s disease detection... Online

Moving towards a new Alzheimer’s disease detection and diagnosis pathway

Learn more →
 
 
 
29 SEP 2023
  Are medicines affordable for health systems? Bad Hofgastein, Austria

The myths, the facts, and the way forward

Learn more →
 
 
 
17 OCT 2023
  EFGCP Better Medicines for Children Conference 2023 Amsterdam

Global Paediatric Drug Development: the value of multi-stakeholders’ collaboration

Learn more →
 
 
      Principles for Responsible Clinical Trial Data Sharing: Our Commitment to Patients and Researchers

In 2014, EFPIA and PhRMA published their Principles for Responsible Clinical Trial Data Sharing, demonstrating the industry’s commitment to support innovation and to comply with and go beyond the legal requirements of clinical trial data sharing. In 2023, to reflect the evolution of EFPIA and PhRMA member company practices, we have revised the wording of these principles.

Read the updated version here.

 

 
 
      What we are reading
Pharma industry: Proposed ‘forever chemicals’ ban would stifle innovation, access to drugs 27 July 2023  (Euractiv) Read more →
Walking the talk in digital transformation of regulatory review 26 July 2023  (Frontiers) Read more →
Modernising EU legislation: The Alliance for Regenerative Medicine makes the case for ATMPs... 20 July 2023  (pharmaphorum) Read more →
    About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

 
Tel: +32 (0)2 626 25 55
Communications@efpia.eu
▶ in
 
EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe